PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as PR-104, docetaxel, and gemcitabine, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor
cells.
PURPOSE: This phase I trial is studying the side effects and best dose of PR-104 when given
together with docetaxel or gemcitabine in treating patients with solid tumors.